SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

CAC 40 NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

AB SCIENCE: Click to view the issuer\'s details

Last update : 29/04/2014  >View issuer details

2019.11.27 | 08:34 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce AB Science will host a live webcast on masitinib in severe asthma on Monday December 2, 2019 - HTML (w)

2019.11.27 | 08:34 | Permanent Information Releases / General Company News

French version HTML (w) Mail

puce AB Science tiendra une web conférence sur le masitinib dans l’asthme sévère le lundi 2 décembre 2019 - HTML (w)

2019.11.26 | 19:15 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce AB Science will host a live webcast on masitinib in severe asthma on December 2, 2019 - HTML (w)

2019.11.26 | 19:15 | Permanent Information Releases / General Company News

French version HTML (w) Mail

puce AB Science tiendra une web conférence sur le masitinib dans l’asthme sévère le 2 décembre 2019 - HTML (w)

2019.11.25 | 08:21 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce AB Science provides the summary of webcast with Key Opinion Leaders on Indolent Systemic Mastocytosis - HTML (w)

2019.11.07 | 20:29 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma - HTML (w)

2019.11.07 | 20:29 | Permanent Information Releases / General Company News

French version HTML (w) Mail

puce AB Science annonce des résultats de phase 3 positifs du masitinib dans l’asthme sévère - HTML (w)

2019.11.07 | 08:26 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce AB Science announces that AB8939 receives Orphan Drug Designation for Acute Myeloid Leukemia from FDA - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 420